53 related articles for article (PubMed ID: 38454277)
21. The stem cell-specific intermediate filament nestin missense variation p.A1199P is associated with pancreatic cancer.
Matsuda Y; Tanaka M; Sawabe M; Mori S; Muramatsu M; Mieno MN; Ishiwata T; Arai T
Oncol Lett; 2019 May; 17(5):4647-4654. PubMed ID: 30988821
[TBL] [Abstract][Full Text] [Related]
22. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche.
Chen SH; Zhang BY; Zhou B; Zhu CZ; Sun LQ; Feng YJ
Am J Cancer Res; 2019; 9(1):1-21. PubMed ID: 30755808
[TBL] [Abstract][Full Text] [Related]
23. Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling.
Alrawashdeh W; Jones R; Dumartin L; Radon TP; Cutillas PR; Feakins RM; Dmitrovic B; Demir IE; Ceyhan GO; Crnogorac-Jurcevic T
Mol Oncol; 2019 May; 13(5):1075-1091. PubMed ID: 30690892
[TBL] [Abstract][Full Text] [Related]
24. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer.
Yang YH; Liu JB; Gui Y; Lei LL; Zhang SJ
World J Gastroenterol; 2017 Oct; 23(40):7232-7241. PubMed ID: 29142470
[TBL] [Abstract][Full Text] [Related]
25. The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
Faleiro I; Apolónio JD; Price AJ; De Mello RA; Roberto VP; Tabori U; Castelo-Branco P
Future Oncol; 2017 Oct; 13(23):2045-2051. PubMed ID: 29019414
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.
Bakst RL; Xiong H; Chen CH; Deborde S; Lyubchik A; Zhou Y; He S; McNamara W; Lee SY; Olson OC; Leiner IM; Marcadis AR; Keith JW; Al-Ahmadie HA; Katabi N; Gil Z; Vakiani E; Joyce JA; Pamer E; Wong RJ
Cancer Res; 2017 Nov; 77(22):6400-6414. PubMed ID: 28951461
[TBL] [Abstract][Full Text] [Related]
27. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.
Nigri J; Gironella M; Bressy C; Vila-Navarro E; Roques J; Lac S; Bontemps C; Kozaczyk C; Cros J; Pietrasz D; Maréchal R; Van Laethem JL; Iovanna J; Bachet JB; Folch-Puy E; Tomasini R
Cell Mol Life Sci; 2017 Nov; 74(22):4231-4243. PubMed ID: 28656348
[TBL] [Abstract][Full Text] [Related]
28. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO
Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579
[TBL] [Abstract][Full Text] [Related]
29. Leucocyte telomere length, genetic variants at the
Bao Y; Prescott J; Yuan C; Zhang M; Kraft P; Babic A; Morales-Oyarvide V; Qian ZR; Buring JE; Cochrane BB; Gaziano JM; Giovannucci EL; Manson JE; Ng K; Ogino S; Rohan TE; Sesso HD; Stampfer MJ; Fuchs CS; De Vivo I; Amundadottir LT; Wolpin BM
Gut; 2017 Jun; 66(6):1116-1122. PubMed ID: 27797938
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer.
Nomura A; Majumder K; Giri B; Dauer P; Dudeja V; Roy S; Banerjee S; Saluja AK
Lab Invest; 2016 Dec; 96(12):1268-1278. PubMed ID: 27775688
[TBL] [Abstract][Full Text] [Related]
31. Impact by pancreatic stellate cells on epithelial-mesenchymal transition and pancreatic cancer cell invasion: Adding a third dimension in vitro.
Karnevi E; Rosendahl AH; Hilmersson KS; Saleem MA; Andersson R
Exp Cell Res; 2016 Aug; 346(2):206-15. PubMed ID: 27443257
[TBL] [Abstract][Full Text] [Related]
32. Neural plasticity in pancreatitis and pancreatic cancer.
Demir IE; Friess H; Ceyhan GO
Nat Rev Gastroenterol Hepatol; 2015 Nov; 12(11):649-59. PubMed ID: 26460352
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.
Chiorean EG; Coveler AL
Drug Des Devel Ther; 2015; 9():3529-45. PubMed ID: 26185420
[TBL] [Abstract][Full Text] [Related]
34. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
Campa D; Rizzato C; Stolzenberg-Solomon R; Pacetti P; Vodicka P; Cleary SP; Capurso G; Bueno-de-Mesquita HB; Werner J; Gazouli M; Butterbach K; Ivanauskas A; Giese N; Petersen GM; Fogar P; Wang Z; Bassi C; Ryska M; Theodoropoulos GE; Kooperberg C; Li D; Greenhalf W; Pasquali C; Hackert T; Fuchs CS; Mohelnikova-Duchonova B; Sperti C; Funel N; Dieffenbach AK; Wareham NJ; Buring J; Holcátová I; Costello E; Zambon CF; Kupcinskas J; Risch HA; Kraft P; Bracci PM; Pezzilli R; Olson SH; Sesso HD; Hartge P; Strobel O; Małecka-Panas E; Visvanathan K; Arslan AA; Pedrazzoli S; Souček P; Gioffreda D; Key TJ; Talar-Wojnarowska R; Scarpa A; Mambrini A; Jacobs EJ; Jamroziak K; Klein A; Tavano F; Bambi F; Landi S; Austin MA; Vodickova L; Brenner H; Chanock SJ; Delle Fave G; Piepoli A; Cantore M; Zheng W; Wolpin BM; Amundadottir LT; Canzian F
Int J Cancer; 2015 Nov; 137(9):2175-83. PubMed ID: 25940397
[TBL] [Abstract][Full Text] [Related]
35. Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML.
Zaitseva L; Murray MY; Shafat MS; Lawes MJ; MacEwan DJ; Bowles KM; Rushworth SA
Oncotarget; 2014 Oct; 5(20):9930-8. PubMed ID: 25294819
[TBL] [Abstract][Full Text] [Related]
36. Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.
Göhrig A; Detjen KM; Hilfenhaus G; Körner JL; Welzel M; Arsenic R; Schmuck R; Bahra M; Wu JY; Wiedenmann B; Fischer C
Cancer Res; 2014 Mar; 74(5):1529-40. PubMed ID: 24448236
[TBL] [Abstract][Full Text] [Related]
37. Neural invasion in pancreatic cancer: the past, present and future.
Demir IE; Ceyhan GO; Liebl F; D'Haese JG; Maak M; Friess H
Cancers (Basel); 2010 Jul; 2(3):1513-27. PubMed ID: 24281170
[TBL] [Abstract][Full Text] [Related]
38. The relationship between multiple clinicopathological features and nerve invasion in pancreatic cancer.
Wang PH; Song N; Shi LB; Zhang QH; Chen ZY
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):546-51. PubMed ID: 24103287
[TBL] [Abstract][Full Text] [Related]
39. Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models.
Pitts TM; Kulikowski GN; Tan AC; Murray BW; Arcaroli JJ; Tentler JJ; Spreafico A; Selby HM; Kachaeva MI; McPhillips KL; Britt BC; Bradshaw-Pierce EL; Messersmith WA; Varella-Garcia M; Eckhardt SG
Front Pharmacol; 2013; 4():35. PubMed ID: 23543898
[TBL] [Abstract][Full Text] [Related]
40. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway.
Li X; Ma Q; Xu Q; Liu H; Lei J; Duan W; Bhat K; Wang F; Wu E; Wang Z
Cancer Lett; 2012 Sep; 322(2):169-76. PubMed ID: 22450749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
